PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEstriol
Estriol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
46 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrophic vaginitisD059268EFO_1001271—2443518
AtrophyD001284——2432617
SyndromeD013577———2—237
VaginitisD014627EFO_0005757N762—1115
ProlapseD011391————1214
Pelvic organ prolapseD056887EFO_0004710———12—3
Breast neoplasmsD001943EFO_0003869C50———112
Endometrial hyperplasiaD004714—N85.0———1—1
HyperplasiaD006965EFO_0000536————1—1
InfectionsD007239EFO_0000544————1—1
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MenopauseD008593EFO_0003922N95221——5
Multiple sclerosisD009103EFO_0003885G35—31——3
SclerosisD012598———31——3
Neurogenic urinary bladderD001750HP_0000011N31—11——1
Pelvic floor disordersD059952————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Premature birthD047928EFO_0003917O60—1——23
Premenstrual syndromeD011293—N94.3—2———2
Relapsing-remitting multiple sclerosisD020529EFO_0003929——2———2
Hereditary hemorrhagic telangiectasiaD013683—I78.0—1———1
EpistaxisD004844EFO_0003895R04.0—1———1
TelangiectasisD013684———1———1
RecurrenceD012008———1———1
HypersensitivityD006967HP_0012393T78.40—1———1
Habitual abortionD000026EFO_1000954N96—1———1
Chronic progressive multiple sclerosisD020528EFO_0003840——1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DyspareuniaD004414HP_0030016—1———12
Physiological sexual dysfunctionD012735——1————1
PregnancyD011247EFO_0002950Z33.11————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PostmenopauseD017698——————33
VulvodyniaD056650—N94.81————22
Vulvar vestibulitisD054515—N94.810————22
Kallmann syndromeD017436Orphanet_478E23.0————11
Down syndromeD004314EFO_0001064Q90————11
Chromosome aberrationsD002869Orphanet_68335—————11
Chromosome disordersD025063EFO_0003831Q99.9————11
Female urogenital diseasesD052776——————11
Urogenital diseasesD000091642——————11
Respiratory distress syndromeD012128EFO_1000637J80————11
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
+
Estriol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,148 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
210 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use